Long-term out of pocket expenditure of people with cancer: comparing health service cost and use for indigenous and non-indigenous people with cancer in Australia.


Journal

International journal for equity in health
ISSN: 1475-9276
Titre abrégé: Int J Equity Health
Pays: England
ID NLM: 101147692

Informations de publication

Date de publication:
12 02 2019
Historique:
received: 23 09 2018
accepted: 28 01 2019
entrez: 14 2 2019
pubmed: 14 2 2019
medline: 26 7 2019
Statut: epublish

Résumé

Indigenous Australians diagnosed with cancer have poorer survival compared to non-Indigenous Australians. We aim to: 1) identify differences by Indigenous status in out-of-pocket expenditure for the first three-years post-diagnosis; 2) identify differences in the quantity and cost of healthcare services accessed; and 3) estimate the number of additional services required if access was equal between Indigenous and non-Indigenous people with cancer. We used CancerCostMod, a model using linked administrative data. The base population was all persons diagnosed with cancer in Queensland, Australia (01JUL2011 to 30JUN2012) (n = 25,553). Each individual record was then linked to their Admitted Patient Data Collection, Emergency Data Information System, Medicare Benefits Schedule (MBS), and Pharmaceutical Benefits Scheme (PBS) records (01JUL2011 to 30JUN2015). We then weighted the population to be representative of the Australian population (approximately 123,900 Australians, 1.7% Indigenous Australians). The patient co-payment charged for each MBS service and PBS prescription was summed for each month from date of diagnosis to 36-months post-diagnosis. We then limited our model to MBS items to identify the quantity and type of healthcare services accessed during the first three-years. On average Indigenous people with cancer had less than half the out-of-pocket expenditure for each 12-month period (0-12 months: mean $401 Indigenous vs $1074 non-Indigenous; 13-24 months: mean $200 vs $484; and 25-36 months: mean $181 vs $441). A stepwise generalised linear model of out-of-pocket expenditure found that Indigenous status was a significant predictor of out of pocket expenditure. We found that Indigenous people with cancer on average accessed 236 services per person, however, this would increase to 309 services per person if Indigenous people had the same rate of service use as non-Indigenous people. Indigenous people with cancer had lower out-of-pocket expenditure, but also accessed fewer Medicare services compared to their non-Indigenous counterparts. Indigenous people with cancer were less likely to access specialist attendances, pathology tests, and diagnostic imaging through MBS, and more likely to access primary health care, such as services provided by general practitioners.

Sections du résumé

BACKGROUND
Indigenous Australians diagnosed with cancer have poorer survival compared to non-Indigenous Australians. We aim to: 1) identify differences by Indigenous status in out-of-pocket expenditure for the first three-years post-diagnosis; 2) identify differences in the quantity and cost of healthcare services accessed; and 3) estimate the number of additional services required if access was equal between Indigenous and non-Indigenous people with cancer.
METHODS
We used CancerCostMod, a model using linked administrative data. The base population was all persons diagnosed with cancer in Queensland, Australia (01JUL2011 to 30JUN2012) (n = 25,553). Each individual record was then linked to their Admitted Patient Data Collection, Emergency Data Information System, Medicare Benefits Schedule (MBS), and Pharmaceutical Benefits Scheme (PBS) records (01JUL2011 to 30JUN2015). We then weighted the population to be representative of the Australian population (approximately 123,900 Australians, 1.7% Indigenous Australians). The patient co-payment charged for each MBS service and PBS prescription was summed for each month from date of diagnosis to 36-months post-diagnosis. We then limited our model to MBS items to identify the quantity and type of healthcare services accessed during the first three-years.
RESULTS
On average Indigenous people with cancer had less than half the out-of-pocket expenditure for each 12-month period (0-12 months: mean $401 Indigenous vs $1074 non-Indigenous; 13-24 months: mean $200 vs $484; and 25-36 months: mean $181 vs $441). A stepwise generalised linear model of out-of-pocket expenditure found that Indigenous status was a significant predictor of out of pocket expenditure. We found that Indigenous people with cancer on average accessed 236 services per person, however, this would increase to 309 services per person if Indigenous people had the same rate of service use as non-Indigenous people.
CONCLUSIONS
Indigenous people with cancer had lower out-of-pocket expenditure, but also accessed fewer Medicare services compared to their non-Indigenous counterparts. Indigenous people with cancer were less likely to access specialist attendances, pathology tests, and diagnostic imaging through MBS, and more likely to access primary health care, such as services provided by general practitioners.

Identifiants

pubmed: 30755217
doi: 10.1186/s12939-019-0931-4
pii: 10.1186/s12939-019-0931-4
pmc: PMC6371603
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Pagination

32

Références

Med J Aust. 2013 Oct 7;199(7):475-8
pubmed: 24099208
Aust J Rural Health. 2011 Dec;19(6):298-305
pubmed: 22098213
Med J Aust. 2005 Mar 21;182(6):277-80
pubmed: 15777142
Eur J Cancer Care (Engl). 2017 Jan;26(1):
pubmed: 26423576
Lancet Oncol. 2008 Jun;9(6):585-95
pubmed: 18510990
Value Health. 2013 Jan-Feb;16(1 Suppl):S39-45
pubmed: 23317643
BMC Cancer. 2014 Jul 18;14:517
pubmed: 25037075
BMC Cancer. 2014 Mar 07;14:163
pubmed: 24606675
Support Care Cancer. 2015 Jun;23(6):1807-17
pubmed: 25471182
Hum Resour Health. 2012 Jan 22;10:1
pubmed: 22264385
Med J Aust. 2004 Aug 16;181(4):191-4
pubmed: 15310252
Aust J Prim Health. 2017 Apr;23(1):15-22
pubmed: 28442033
Psychooncology. 2007 Dec;16(12):1130-9
pubmed: 17345557
Aust N Z J Public Health. 2009 Oct;33(5):458-65
pubmed: 19811484
Lancet. 2006 Jun 3;367(9525):1842-8
pubmed: 16753487
Health Policy. 2017 Apr;121(4):426-433
pubmed: 28237388
Int J Epidemiol. 2000 Oct;29(5):813-6
pubmed: 11034962
Popul Health Metr. 2014 Jan 31;12(1):1
pubmed: 24479861
BMJ Open. 2017 Jan 24;7(1):e014030
pubmed: 28119391
Patient. 2017 Jun;10(3):295-309
pubmed: 27798816
Aust J Rural Health. 2009 Dec;17(6):321-9
pubmed: 19930199
Psychooncology. 2017 Jun;26(6):849-855
pubmed: 27479170

Auteurs

Emily Callander (E)

School of Medicine, Griffith University, Gold Coast, Australia. e.callander@griffith.edu.au.
Australian Institute of Tropical Health and Medicine (AITHM), James Cook University, Townsville, Australia. e.callander@griffith.edu.au.

Nicole Bates (N)

Australian Institute of Tropical Health and Medicine (AITHM), James Cook University, Townsville, Australia.
College of Public Health, Medical and Veterinary Sciences (CPHMVS), James Cook University, Townsville, Australia.

Daniel Lindsay (D)

College of Public Health, Medical and Veterinary Sciences (CPHMVS), James Cook University, Townsville, Australia.

Sarah Larkins (S)

College of Medicine and Dentistry (CMD), James Cook University, Townsville, Australia.

Stephanie M Topp (SM)

College of Public Health, Medical and Veterinary Sciences (CPHMVS), James Cook University, Townsville, Australia.

Joan Cunningham (J)

Menzies School of Health Research, Charles Darwin University, Darwin, Australia.

Sabe Sabesan (S)

College of Medicine and Dentistry (CMD), James Cook University, Townsville, Australia.

Gail Garvey (G)

Menzies School of Health Research, Charles Darwin University, Darwin, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH